Log In
Print
BCIQ
Print
Print this Print this
 

CLR-610 (formerly OriTex)

  Manage Alerts
Collapse Summary General Information
Company Clarus Therapeutics Inc.
DescriptionOral testosterone
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPhase III
IndicationHypogonadism
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today